naa a22 4500 510763782 CHVBK 20180411083149.0 cr unu---uuuuu 180411e20130301xx s 000 0 eng 10.1007/s12094-012-0913-0 doi (NATIONALLICENCE)springer-10.1007/s12094-012-0913-0 Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009 [Elektronische Daten] [Almudena Zapatero, José López-Torrecilla, Ismael Herruzo, Felipe Calvo] Introduction: Little is known of practice patterns on advanced prostate cancer (PC) in Spain. The study objectives were to investigate practice patterns in the management of PC and to determine the adherence to the 2007 Spanish guidelines for the management of PC. Materials and methods: An epidemiological, cross-sectional study was undertaken. Study-specific questionnaires were distributed to all centers with radiation oncology (RO) facilities delivering megavoltage radiation therapy (RT) in Spain (n=108). A questionnaire evaluated diagnostic and treatment approaches to PC in low-risk and high-risk cases. And a 12-item questionnaire was used to assess guidelines adherence. Results: Responses were obtained from 102 centers (94.0% response rate). In the high-risk scenario, the majority of clinicians (99.0%) chose combined modality treatment with RT and androgen deprivation (AD) and 93.0% recommended long-term AD. External-beam RT (EBRT) doses ranging 72-76Gy were used in 59.5% of centers and >76Gy was employed in 40.5%. In the low-risk scenario, EBRT was chosen by 59.6%, brachytherapy by 39.4%, and active surveillance by 1%. The consensus was high (score 5+4≥90%) on 8/12 questions assessing adherence to guidelines, being high specifically on items related to RT technique, RT dose, combination of HT and RT in intermediate/high-risk patients, and prognostic factors. Conclusions: This is the largest survey to date of Spanish RO departments dealing with PC. The study results therefore likely provide a highly reliable picture of clinical practice in Spain in this century and show how this practice is influenced by clinical evidence from randomized trials and consensus conferences. Federación de Sociedades Españolas de Oncología (FESEO), 2012 Prostate cancer nationallicence Physician practice patterns nationallicence Radiotherapy nationallicence Brachytherapy nationallicence Hormone therapy nationallicence Zapatero Almudena Department of Radiation Oncology, Health Research Institute IP, Hospital Universitario de la Princesa, Diego de León, 62, 28006, Madrid, Spain aut López-Torrecilla José Department of Radiation Oncology-ERESA, Hospital General Universitario, Valencia, Spain aut Herruzo Ismael Department of Radiation Oncology, Hospital Universitario Carlos Haya, Málaga, Spain aut Calvo Felipe Department of Oncology, Hospital Universitario Gregorio Marañón, Madrid, Spain aut Clinical and Translational Oncology Springer Milan 15/3(2013-03-01), 226-232 1699-048X 15:3<226 2013 15 12094 https://doi.org/10.1007/s12094-012-0913-0 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s12094-012-0913-0 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Zapatero Almudena Department of Radiation Oncology, Health Research Institute IP, Hospital Universitario de la Princesa, Diego de León, 62, 28006, Madrid, Spain aut NATIONALLICENCE 700 1- López-Torrecilla José Department of Radiation Oncology-ERESA, Hospital General Universitario, Valencia, Spain aut NATIONALLICENCE 700 1- Herruzo Ismael Department of Radiation Oncology, Hospital Universitario Carlos Haya, Málaga, Spain aut NATIONALLICENCE 700 1- Calvo Felipe Department of Oncology, Hospital Universitario Gregorio Marañón, Madrid, Spain aut NATIONALLICENCE 773 0- Clinical and Translational Oncology Springer Milan 15/3(2013-03-01), 226-232 1699-048X 15:3<226 2013 15 12094 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer